InterCure Ltd. (TLV: INCR)
Israel
· Delayed Price · Currency is ILS · Price in ILA 613.90
-6.10 (-0.98%)
Jan 21, 2025, 5:24 PM IDT
InterCure Revenue
InterCure had revenue of 62.87M ILS in the quarter ending June 30, 2024, a decrease of -38.63%. This brings the company's revenue in the last twelve months to 272.67M, down -34.26% year-over-year. In the year 2023, InterCure had annual revenue of 355.55M, down -8.52%.
Revenue (ttm)
272.67M
Revenue Growth
-34.26%
P/S Ratio
1.04
Revenue / Employee
1.01M
Employees
270
Market Cap
280.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 355.55M | -33.13M | -8.52% |
| Dec 31, 2022 | 388.68M | 169.01M | 76.93% |
| Dec 31, 2021 | 219.68M | 154.64M | 237.78% |
| Dec 31, 2020 | 65.04M | 56.11M | 628.60% |
| Dec 31, 2019 | 8.93M | - | - |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 62.35B |
| Danel (Adir Yeoshua) | 2.71B |
| Kamada | 588.75M |
| Bait Bakfar | 102.08M |
| Novolog (Pharm-Up 1966) | 1.73B |
| Ilex Medical | 982.96M |
| BrainsWay | 143.60M |
| SofWave Medical | 210.53M |